Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schaeffer

Showing results (651-660 of 790) with videos related to

Pageof 79
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2021
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancerTamara L Lotan, Harsimar B Kaur, Daniela C Salles, et al.
Human Pathology|March 10, 2019
TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancerHarsimar B Kaur, Jiayun Lu, Liana B Guedes, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.
International Journal of Cancer|May 14, 2020
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based studyTravis J Meyers, Adam B Weiner, Rebecca E Graff, et al.
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Prostate Cancer and Prostatic Diseases|May 13, 2022
Real-world use of MRI for risk stratification prior to prostate biopsyMohammad R Siddiqui, Brandon Ansbro, Parth V Shah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 2018
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancerHarsimar B Kaur, Liana B Guedes, Jiayun Lu, et al.
European Urology Oncology|July 7, 2024
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results RegistryAlec Zhu, James A Proudfoot, Elai Davicioni, et al.
European Urology|August 2, 2016
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical ProstatectomyJeffrey J Tosoian, Fawaz Almutairi, Carlos L Morais, et al.
Pageof 79

Showing results (651-660 of 790) with videos related to

Sort By:
Pageof 79
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2021
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancerTamara L Lotan, Harsimar B Kaur, Daniela C Salles, et al.
Human Pathology|March 10, 2019
TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancerHarsimar B Kaur, Jiayun Lu, Liana B Guedes, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.
International Journal of Cancer|May 14, 2020
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based studyTravis J Meyers, Adam B Weiner, Rebecca E Graff, et al.
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Prostate Cancer and Prostatic Diseases|May 13, 2022
Real-world use of MRI for risk stratification prior to prostate biopsyMohammad R Siddiqui, Brandon Ansbro, Parth V Shah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 2018
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancerHarsimar B Kaur, Liana B Guedes, Jiayun Lu, et al.
European Urology Oncology|July 7, 2024
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results RegistryAlec Zhu, James A Proudfoot, Elai Davicioni, et al.
European Urology|August 2, 2016
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical ProstatectomyJeffrey J Tosoian, Fawaz Almutairi, Carlos L Morais, et al.
Pageof 79